SureTrader
Interactive Brokers Advertisement
Home > Boards > Other Markets > Foreign Stock Markets > Saniona (Sanion)

PRESS RELEASE

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Swe_bio_ Member Profile
 
Followed By 0
Posts 7
Boards Moderated 1
Alias Born 05/13/17
160x600 placeholder
Swe_bio_   Tuesday, 10/03/17 06:11:40 PM
Re: None
Post # of 4 
PRESS RELEASE

2017-09-18 08:00


Saniona AB: Saniona reports encouraging start for tesofensine Phase 3 study (GlobeNewswire)

"Saniona, a leading biotech company in the field of ion channels, today announces that Saniona's partner, Medix, has recruited 150 out of the planned 372 patients in the study during the first six weeks."

https://www.avanza.se/placera/pressmeddelanden/2017/09/18/saniona-saniona-ab-saniona-reports-encouraging-start-for-tesofensine-phase-3-study.html

PRESS RELEASE

October 3, 2017


"Saniona, a leading biotech company in the field of ion channels, today announces that it has reached the third research milestone for identifying new drug candidates for the treatment of Parkinson's disease, which is supported by The Michael J. Fox Foundation for Parkinson's Research (MJFF)."

https://www.avanza.se/placera/pressmeddelanden/2017/10/03/saniona-saniona-ab-saniona-obtains-research-milestone-from-the-michael-j-fox-foundation-for-parkinsons-research.html

[t][/t]


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist